News | August 23, 2023
Jupiter Life Line Hospitals raised Rs. 123 crore in pre IPO round
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting
The company has new projects in development in Mumbai, Punjab, central and northern India, among others
Bromfenac Ophthalmic Solution 0.09% (RLD Bromday) had estimated annual sales of USD 11 million in the U.S. (IQVIA MAT June 2023).
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
Subscribe To Our Newsletter & Stay Updated
